search
Back to results

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury (ABMST-SCI)

Primary Purpose

Spinal Cord Injuries

Status
Completed
Phase
Phase 1
Locations
India
Study Type
Interventional
Intervention
laminectomy
Intrathecal
Sponsored by
International Stemcell Services Limited
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries

Eligibility Criteria

20 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Must be able to give voluntary (patients may not be able to write) consent.
  2. Must be able to understand study information provided to him.
  3. Patients with complete spinal cord trans-section: at least post 6 months after spinal cord Injury (in chronic patients), < 2 weeks in acute category and 2-8 weeks in subacute patients.
  4. The level of spinal cord injury must be between C4 and T12(neurological level)
  5. Spinal cord injury categorized in terms of ASIA Impairment scale.
  6. Age should be between 20-55 years

Exclusion Criteria:

  • Mechanical ventilation due to neurological impairment
  • Multiple level trauma
  • Undetermined size and location of Spinal Cord injury
  • Gunshot or other penetrating trauma to the spinal cord
  • Longitudinal dimension of injury by MRI is greater than 3spinal segments
  • Associated severe head injury
  • More than 9cms long bone fracture
  • Women who are pregnant or lactating
  • Serious pre-existing medical conditions
  • Disease or impairment that precludes adequate neurological examination.
  • Should not have co-morbidities like Diabetes, Systemic Hypertension etc.
  • Severe co-morbidities/bed sores Tests positive for infectious diseases Deranged Coagulation profile and Hb < 8mg/dl

Sites / Locations

  • Sita Bhateja Speciality Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Intralesional

intrathecal

Arm Description

Surgical transplantation into the lesion site in chronic patients Direct intrathecal implantation in acute and subacute patients

direct into the CSF through lumbar puncture

Outcomes

Primary Outcome Measures

Number of Participants with adverse events as a measure of safety and tolerability. Significant clinical improvement in ASIA impairment scale and general condition
American Spinal Injury Assessment scale of A,B,C,D or E

Secondary Outcome Measures

Changes in the MRI, Neurological improvement (cranial/spinal reflexes) and evoked potentials study
MRI findings of the lesion, Nerve conduction studies of the region and somatosensory evoked potentials of the same region

Full Information

First Posted
August 20, 2010
Last Updated
August 20, 2010
Sponsor
International Stemcell Services Limited
search

1. Study Identification

Unique Protocol Identification Number
NCT01186679
Brief Title
Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury
Acronym
ABMST-SCI
Official Title
Surgical Transplantation of Autologous Bone Marrow Stem Cells With Glial Scar Resection for Patients of Chronic Spinal Cord Injury and Intra-thecal Injection for Acute and Subacute Injury - A Preliminary Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2010
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
February 2010 (Actual)
Study Completion Date
August 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
International Stemcell Services Limited

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The projected data related to the burden of spinal cord injuries induced limb paralysis in India is quite alarming. This is attributed to the rapid industrialization and economical development in the country. Increase in vehicular traffic has caused numerous road traffic accidents. Rapid increase in populations, development in the computer technology and real estate business lead to construction of huge buildings which indirectly adds to the injuries due to fall. Spinal cord injuries could not be treated adequately with the prevailing treatment modalities. In view of this, there is definitely an urgent need for finding different methods of treatment for these patients who cannot undergo established modalities of treatment or these have been tried unsuccessfully. Since a large number of these patients will loose their productive life and at the prime of their lives, one such alternate therapy, which seems to offer some promise, is "stem cell" therapy, which has been well studied and published in prestigious journals. In our present study, we want to evaluate the safety and efficacy of autologous bone marrow derived stem cells surgically transplanted directly into the lesion site with glial scar resection for 8 indian patients of chronic spinal cord injury and intra-thecal injection for 4 indian patients of acute and subacute injury.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
12 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intralesional
Arm Type
Experimental
Arm Description
Surgical transplantation into the lesion site in chronic patients Direct intrathecal implantation in acute and subacute patients
Arm Title
intrathecal
Arm Type
Experimental
Arm Description
direct into the CSF through lumbar puncture
Intervention Type
Procedure
Intervention Name(s)
laminectomy
Intervention Description
surgical laminectomy with glial scar resection
Intervention Type
Procedure
Intervention Name(s)
Intrathecal
Intervention Description
direct into the CSF through lumbar puncture
Primary Outcome Measure Information:
Title
Number of Participants with adverse events as a measure of safety and tolerability. Significant clinical improvement in ASIA impairment scale and general condition
Description
American Spinal Injury Assessment scale of A,B,C,D or E
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Changes in the MRI, Neurological improvement (cranial/spinal reflexes) and evoked potentials study
Description
MRI findings of the lesion, Nerve conduction studies of the region and somatosensory evoked potentials of the same region
Time Frame
18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Must be able to give voluntary (patients may not be able to write) consent. Must be able to understand study information provided to him. Patients with complete spinal cord trans-section: at least post 6 months after spinal cord Injury (in chronic patients), < 2 weeks in acute category and 2-8 weeks in subacute patients. The level of spinal cord injury must be between C4 and T12(neurological level) Spinal cord injury categorized in terms of ASIA Impairment scale. Age should be between 20-55 years Exclusion Criteria: Mechanical ventilation due to neurological impairment Multiple level trauma Undetermined size and location of Spinal Cord injury Gunshot or other penetrating trauma to the spinal cord Longitudinal dimension of injury by MRI is greater than 3spinal segments Associated severe head injury More than 9cms long bone fracture Women who are pregnant or lactating Serious pre-existing medical conditions Disease or impairment that precludes adequate neurological examination. Should not have co-morbidities like Diabetes, Systemic Hypertension etc. Severe co-morbidities/bed sores Tests positive for infectious diseases Deranged Coagulation profile and Hb < 8mg/dl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr.Arvind Bhateja, MCh.Neurosurgery
Organizational Affiliation
Sita Bhateja Speciality Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sita Bhateja Speciality Hospital
City
Bangalore
State/Province
Karnataka
ZIP/Postal Code
560025
Country
India

12. IPD Sharing Statement

Learn more about this trial

Safety and Efficacy of Autologous Bone Marrow Stem Cells in Treating Spinal Cord Injury

We'll reach out to this number within 24 hrs